ALB
Albemarle Corporation NYSE$190.69
Mkt Cap $22.5B
52w Low $53.70
84.6% of range
52w High $215.71
50d MA $178.89
200d MA $129.96
P/E (TTM)
-33.7x
EV/EBITDA
24.3x
P/B
2.3x
Debt/Equity
0.3x
ROE
-5.4%
P/FCF
24.0x
RSI (14)
—
ATR (14)
—
Beta
1.43
50d MA
$178.89
200d MA
$129.96
Avg Volume
2.3M
About
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries f…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | AMC | -0.42 | -0.53 | -26.9% | 175.43 | -1.4% | -9.4% | -5.2% | -3.7% | -2.4% | -4.0% | — |
| Nov 5, 2025 | AMC | -0.86 | -0.19 | +77.9% | 91.96 | +2.2% | -0.8% | +5.7% | +12.6% | +13.0% | +20.0% | — |
| Jul 30, 2025 | AMC | -0.83 | 0.11 | +113.3% | 68.89 | +1.7% | -1.5% | -1.4% | -0.5% | -0.9% | -2.3% | — |
| Apr 30, 2025 | AMC | -0.62 | -0.18 | +71.0% | 58.55 | +4.8% | +1.3% | +3.0% | -1.0% | -1.8% | -4.3% | — |
| Feb 12, 2025 | AMC | -0.60 | -1.09 | -81.7% | 76.60 | +4.3% | +3.5% | +6.0% | +9.1% | +9.2% | +7.7% | — |
| Nov 6, 2024 | AMC | -0.44 | -1.55 | -253.2% | 96.58 | +0.8% | +3.5% | +4.4% | +14.4% | +6.4% | +12.0% | — |
| Jul 31, 2024 | AMC | 0.53 | 0.04 | -92.5% | 93.67 | +0.4% | -0.5% | -7.1% | -10.8% | -15.1% | -15.6% | — |
| May 1, 2024 | AMC | 0.25 | 0.26 | +2.9% | 119.00 | -1.3% | +5.3% | +7.6% | +9.9% | +10.5% | +9.6% | — |
| Feb 14, 2024 | AMC | 0.99 | 1.85 | +86.9% | 114.39 | -2.1% | +2.7% | +7.2% | +0.4% | +3.6% | +3.3% | — |
| Nov 1, 2023 | AMC | 3.99 | 2.74 | -31.3% | 122.96 | -3.2% | +1.4% | +4.1% | -2.8% | -0.7% | -3.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | RBC Capital | Maintains | Outperform → Outperform | — | $193.14 | $191.00 | -1.1% | -2.5% | +3.3% | -3.2% | -1.2% | +1.8% |
| Apr 22 | Rothschild & Co Redburn | Downgrade | Buy → Neutral | $188 | $198.42 | $200.00 | +0.8% | -2.1% | -2.7% | -5.1% | +0.6% | -5.8% |
| Apr 22 | Truist | Maintains | Buy → Buy | — | $198.42 | $200.00 | +0.8% | -2.1% | -2.7% | -5.1% | +0.6% | -5.8% |
| Apr 21 | Citigroup | Maintains | Neutral → Neutral | — | $194.83 | $195.12 | +0.1% | +1.8% | -0.3% | -0.9% | -3.3% | +2.4% |
| Apr 21 | BofA Securities | Maintains | Buy → Buy | — | $194.83 | $195.12 | +0.1% | +1.8% | -0.3% | -0.9% | -3.3% | +2.4% |
| Apr 17 | Baird | Downgrade | Outperform → Neutral | — | $215.62 | $207.56 | -3.7% | -8.3% | -9.6% | -8.0% | -9.9% | -10.4% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $177.44 | $176.48 | -0.5% | -2.9% | -2.1% | +4.5% | +7.0% | +4.5% |
| Feb 18 | Evercore ISI | Maintains | In Line → In Line | — | $168.92 | $171.80 | +1.7% | +1.4% | -0.3% | -0.3% | +5.1% | +10.6% |
| Feb 17 | RBC Capital | Maintains | Outperform → Outperform | — | $166.35 | $166.27 | -0.0% | +1.5% | +2.9% | +1.2% | +1.2% | +6.7% |
| Feb 17 | BofA Securities | Upgrade | Neutral → Buy | — | $166.35 | $166.27 | -0.0% | +1.5% | +2.9% | +1.2% | +1.2% | +6.7% |
Recent Filings
8-K
Albemarle Corporation -- 8-K Filing
I cannot provide a meaningful analysis based on this filing summary, as it contains only technical XBRL metadata descriptions rather than substantive business information about Albemarle Corporation.
Apr 17
8-K · 8.01
!! High
Albemarle Corporation -- 8-K 8.01: Material Event / Announcement
Albemarle Corporation filed a material announcement via 8-K, though the specific details require review of the attached press release exhibit to assess potential investor impact.
Mar 6
8-K · 7.01
! Medium
Albemarle Corporation -- 8-K 7.01: Regulation FD Disclosure
Albemarle Corporation announced executive leadership appointments, signaling potential strategic shifts in operations and management direction that investors should monitor for impact on company performance.
Mar 4
8-K
Albemarle Corporation -- 8-K Filing
Albemarle reported a $414 million fourth-quarter net loss, including a Ketjen asset write-down related to an expected transaction, though adjusted losses were narrower at $0.53 per share.
Feb 11
Data updated apr 24, 2026 5:07pm
· Source: massive.com